publication venue for
- Preserved insulin secretory capacity and weight loss are the predominant predictors of glycemic control in patients with type 2 diabetes randomized to roux-en-Y gastric bypass 2015
- A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women 2012
- A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women 2012
- Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy 1985
- Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII 1985
- Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion 1985
- Better care strategies are necessary to address poor medication adherence [abstract] 2020
- Change in A1C with and without intermittent use of CGM in adults with type 2 diabetes participating in the Onduo Virtual Diabetes Clinic [abstract] 2020
- Cross-study comparisons done right: an illustration using two pivotal trials of closed-loop systems [abstract] 2020
- Derived time-in-range is associated with MACE in T2D: data from the DEVOTE Trial [abstract] 2020
- Differences in chronic kidney disease management in patients with and without diabetes in a large care delivery system [abstract] 2020
- First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract] 2020
- Freestyle Libre system use is associated with reduction in inpatient and outpatient emergency acute diabetes events and all-cause hospitalizations in patients with type 2 diabetes [abstract] 2020
- Glycemic relapse: major threat to ongoing improvement in diabetes care [abstract] 2020
- Patient-reported outcomes for 2,335 adults with type 2 diabetes using the omnipod insulin management system show glycemic improvement over first 90 days of use [abstract] 2020
- Patients’ interpretation of Ambulatory Glucose Profile (AGP), CGM, and pump reports [abstract] 2020
- Safety and glycemic outcomes of the MiniMed advanced hybrid closed-loop (AHCL) system in subjects with T1D [abstract] 2020
- Ultra-Rapid Lispro (URLi) demonstrates similar time-in-target range to Humalog with the Medtronic MiniMed 670G Hybrid Closed-Loop System [abstract] 2020
- Utilization of continuous glucose monitors is associated with reduction in inpatient and outpatient emergency acute diabetes events regardless of prior blood test strip usage [abstract] 2020
- A comparison of the impact of the 2017 ACC/AHA hypertension guidelines on primary care populations with and without diabetes [abstract] 2018
- Alogliptin in triple therapy with metformin and sulfonylureas provides significant reductions in HbA1c and is well tolerated: an analysis from the EXAMINE Trial [abstract] 2016
- Can financial incentives prevent diabetes in a low-income population? [abstract 268-OR] 2016
- Comparative effectiveness of two diabetes clinical decision support systems on cardiometabolic outcomes and CV risk: randomized trial [abstract 2304-PUB] 2016
- Designing outpatient diabetes care clinical decision support systems for high use rates [abstract 2309-PUB] 2016
- Double-blind mealtime faster-acting insulin aspart vs. insulin aspart in basal-bolus improves glycemic control in T1D: the Onset 1 Trial [abstract #293-OR] 2016
- Effect of empagliflozin on nephropathy in subgroups by age: results from EMPA-REG outcome [abstract 1198-P] 2016
- Efficacy and safety of LixiLan vs. insulin glargine according to baseline characteristics in patients with type 2 diabetes from the LixiLan-L Trial [abstract 1018-P] 2016
- Efficacy and safety of the insulin glargine plus lixisenatide fixed-ratio combination vs. insulin glargine in patients wth T2DM: the LixiLan-L trial [abstract 238-OR] 2016
- Eliciting patient treatment preferences using a clinical decision support system [abstract 1252-P] 2016
- Hypoglycemia is associated with increased risk of cardiovascular events: results from the EXAMINE Trial [abstract 1091-P] 2016
- Long-term impact of intensive glucose, blood pressure, or lipid control on health utility: ACCORDION Study [abstract 352-OR] 2016
- Mortality findings from the EXAMINE Trial [abstract 1090-P] 2016
- Overuse and underuse of aspirin for primary prevention [abstract 1225-P] 2016
- Are composite measures of diabetes quality of care associated with major CV events [abstract 440-P]? 2015
- Disseminating web-based EHR-linked diabetes clinical decision support system from one medical group to another: case study [abstract 1377-P] 2015
- Early response to liraglutide 3.0 mg in adults with overweight or obesity and type 2 diabetes: subanalysis of the SCALE Diabetes Trial [abstract] 2015
- Evaluation of provider experience with an EHR-based clinical decision support tool [abstract] 2015
- Factors associated with reduced hypoglycemia awareness (RHA) in older adults with type 1 diabetes (T1D) [abstract] 2015
- Glucose variability in type 2 diabetes: the initial results of the FLAT-SUGAR trial [abstract 385-OR] 2015
- Glycemic variability correlated with 1.5-anhydroglucitol (1.5 AHG) but not with markers of oxidation, inflammation, and endothelial function: baseline characteristics of the CAROLINA CGM sub-study [abstract] 2015
- How to minimize future CV events and total mortality in adults with diabetes: lessons from the 10,000,000 person-year SUPREME Cohort Study [abstract] 2015
- Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P] 2015
- Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract 12-OR] 2015
- Severe hypoglycemia in a large cohort of adults with diabetes mellitus treated in U.S. integrated health care delivery systems, 2005-2011 [abstract 390-P] 2015
- Superior reduction of HbA1c in a double-blind, randomized study of basal insulin peglispro (BIL) vs. insulin glargine (GL) in patients (pts) with T1D: IMAGINE 3 [abstract] 2015
- Surveillance of cardiovascular events and total mortality among insured adults with and without diabetes: the SUPREME Cohort Study [abstract 55-OR] 2015
- Sustained use of a diabetes clinical decision support tool in primary care practices [abstract] 2015
- Trends in diabetes control and insulin use in the U.S., 1998-2010 [abstract] 2015
- Educating resident physicians using virtual case-based simulation improves diabetes management--a randomized, controlled trial [abstract 322-OR] 2014
- Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes [abstract] 2014
- Costs associated with delivering intensive or standard glucose, lipids, and systolic blood pressure control strategies in the ACCORD Trial [abstract] 2013
- Glucose screening and identification of pre-diabetes in children and adolescents 2007-2011 [abstract] 2013
- Virtual diabetes education improves resident physician knowledge and performance: a cluster-randomized trial [abstract] 2013
- Weight loss and metabolic response to a commercial weight loss program in type 2 diabetes [abstract] 2013
- Are outcomes from diabetes self-management education sustained? A randomized controlled trial [abstract 666-P] 2012
- Diabetes prevalence among 7 million adult HMO members, 2005-2009: The SUPREME-DM Project [abstract] 2012
- Five-year incidence of diabetes among 6.7 million adult HMO members: the SUPREME-DM Project [abstract] 2012
- Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract 134-OR] 2012
- Simulated diabetes training helps providers bring patients to goals: a cluster randomized trial [abstract 1191-P] 2012
- Simulated training improves provider knowledge and confidence in managing diabetes [abstract 1215-P] 2012
- Correlation between provider use rates of a clinical decision support tool and diabetes performance measures [e-poster 1266-P] 2016